March 26, 2021 /

Webinar: Santhera Pharmaceuticals Duchenne Drug Development Update (March 24, 2021)

Santhera Pharmaceuticals joined Parent Project Muscular Dystrophy (PPMD) for a webinar on March 24, 2021 to provide an update to the community about the investigational therapy vamorolone, the use of steroids to treat Duchenne muscular dystrophy, clinical trials for vamorolone, and development timelines.

Posted on March 26, 2021

Join Our Mailing List